News

DELCO Today on MSN20h
Malvern Medical Manufacturer Cleared for First-of-Its-Kind Alzheimer’s Blood Test
A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has ...
"Important" Alzheimer's treatment breakthrough gets FDA approval
Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...
BusinessMirror9h
FDA clears breakthrough blood test for Alzheimer’s disease diagnosis
Fujirebio recently announced that the US Food and Drug Administration (FDA) has granted clearance for the company’s Lumipulse in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in ...
The Scientist3d
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
BioWorld4d
Fujirebio Alzheimer’s test wins first FDA clearance
Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...
Verywell Health on MSN10h
A Simple Blood Test Could Improve Early Alzheimer’s Disease Detection
The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...
Fierce Pharma13h
Fierce Pharma Asia—Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim spinoff
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...